PHARMAHEALTH

Active

Private limited companyfounded 1982active for 43 yearsKloosterstraat 92, 9620 Zottegem, BelgiumKBO/BCE: BE 0423.649.181

From the official registers: KBO 43 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

PHARMAHEALTH has been active since 1982 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €115,370 and a net result of €10,349. Equity is shrinking by about 4.3% per year across the filed financial years. Its solvency ranks better than 30% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisFollow Report Compare

PHARMAHEALTHActiveChecked score 85/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 30-12-1982 Normal situation
Legal form: Private limited company
Registered office: Kloosterstraat 92, 9620 Zottegem
Activity: Retail sale of pharmaceutical products NACE 47730and 2 others
Establishment unit: 2.021.752.687 9620 Zottegem, since 30-12-1982
Financial year end: 31 December
Peppol: Reachable since 03-01-2025

Company details

Who decides

Board

Pedes Consult BVDirector

Shareholders

Pedes Consult100%annual accounts 2025

Board & ownership

How it is doing

85 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.3%

Annual accounts 2025

Gross margin: €135,678; ▼ 39.1%
Turnover: ≈ €630,000; estimated
Profit: €10,349; ▼ 87.0%
Equity: €115,370; ▼ 25.6%
Total assets: €607,296; ▲ 8.5%
Staff: 1.9 FTE; ▼ 9.5%

2025 accounts 85 days early

Filed on 07-05-2026PDF

Financials

Why 85raises riskSector: Retail trade (NACE 47)Equity €115,370 (19.0% of total assets)lowers riskLiquidity: current ratio 1.41, cash €121,434Founded in 1982Show the evidence

Checked score

Score 2025

85 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 34% of its sector peers (NACE 47, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Average

Solvency 44-9

equity 19.0% of total assets

Liquidity 40-15

short-term debt 65.4% · cash 20.0%

Profitability 66-20

return on assets 1.7%

Bankruptcy probability, 12 months

0.3% Very low

0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026lowest value 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.3%▲ +0.2 percentage points vs 05-2026highest value 07-2026: 0.3%● unchanged vs 06-2026highest value 08-2026: 0.3%● unchanged vs 07-2026highest value 09-2026: 0.3%● unchanged vs 08-2026highest value 10-2026: 0.3%● unchanged vs 09-2026highest value

Credit of up to €9,000 on 30-day terms is acceptable

Liquidity tight (current ratio 1.41, compared with 1.71 in 2024, below the usual 1.5; short-term debt: 65.4% and cash: 20% of total assets), and 81% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 35% on solvency, 38% on liquidity, 47% on profitability and 17% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Sector: Retail trade (NACE 47)

KBO

Liquidity: current ratio 1.41, cash €121,434

NBB · annual accounts

Equity €115,370 (19.0% of total assets)

NBB · annual accounts

Founded in 1982

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-05-2026, 85 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

85 days early

2024

35 days early

2023

34 days early

2022

39 days early

2021

38 days early

2020

58 days early

2019

57 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 49 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 June (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Caution: Result fell in 2025from €79,376 to €10,349 ▼ 87.0% View
Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
Positive: 8 profitable years in a rowprofit 2025: €10,349 8 years View

Documents

Key facts about PHARMAHEALTH

What is the company number of PHARMAHEALTH?: 0423.649.181. In Belgium the VAT number is the company number with BE in front: BE 0423.649.181.
Where is PHARMAHEALTH based?: The registered office is at Kloosterstraat 92, 9620 Zottegem.Company details
What does PHARMAHEALTH do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMAHEALTH?: Private limited company (BV).
When was PHARMAHEALTH founded?: On 30-12-1982.
Is PHARMAHEALTH still active?: Yes, PHARMAHEALTH is an active enterprise in the KBO register.
How many employees does PHARMAHEALTH have?: On average 1.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMAHEALTH?: ≈ €630,000 in financial year 2025. Estimated from the gross margin of €135,678: probably between €430,000 and €1.2m, based on 51 comparable companies, NACE 477.
Is PHARMAHEALTH profitable?: In financial year 2025, PHARMAHEALTH made a profit of €10,349.
Where can I find the annual accounts of PHARMAHEALTH?: PHARMAHEALTH filed 43 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of PHARMAHEALTH due?: By 31-07-2027, for financial year 2026.Timeline